Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for severe periodontitis non-surgical treatment failure
2018-000741-39Phase 3Terminated
- Sponsor
- Strasbourg University Hospital
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic periodontitis comparing Azithromycin plus non-surgical periodontal treatment with Placebo plus non-surgical periodontal treatment (2 arms). Primary endpoint: Treatment failure at 6 months. Started Sep 2019; status: terminated.
02
Drugs
azithromycin
03
Conditions
chronic periodontitis
Beyond the preview
Go deeper on 2018-000741-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000741-39.